Nasdaq · CIK 0001641631
XAIR Beyond Air, Inc.
Insider trading from SEC Form 4. Last filing 12 d ago. Close $2.31 on Oct 12, 2026, +3% from the 52-week low and -96% from the high.
In brief
Beyond Air, Inc. (XAIR) has 50 SEC Form 4 filings on file from 9 insiders, the latest filed on Oct 2, 2026. In the last 90 days insiders made 3 open-market buys worth $282k and 0 open-market sells worth $0, net +$282k.
11 open-market trades have been scored at XAIR. The newest: Yi-Chien Lin (10% owner) bought $57k of stock on Sep 29, 2026, filed Oct 2, 2026, scored 35 (weak). The largest of the 11 shown: Robert Carey (director) bought $2.0M on Dec 18, 2023, scored 66 (notable). 2 insiders bought within 14 days of each other around Jul 29, 2026.
1 Form 144 notice of planned sales is on file, the latest filed Dec 29, 2023.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Beyond Air, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 35Weak | Yi-Chien Lin owner buy | $57k 20,393 shares | +16% | +9% from low-95% from high | |
| 56Moderate | Daniel J Moorhead Chief Financial Officer buy | $25k 4,340 shares | - | +7% from low-92% from high | |
| 73Notable | Robert Scott Goodman Chief Executive Officer buy | $200k 34,722 shares | first purchase | +7% from low-92% from high | |
| 38Weak | Steven A. Lisi CEO and Chairman of the Board buy | $19k 6,000 shares | +0% | +9% from low-75% from high | |
| 34Weak | Robert Carey director buy | $250k 1,000,000 shares | +33% | - | |
| 23Weak | Michael A. Gaul Chief Operating Officer buy | $2,294 6,000 shares | +7% | - | |
| 30Weak | Amir Avniel Chief Business Officer sell | $51k 25,000 shares | -4% | +49% from low-72% from high | |
| 23Weak | Jeff Lynn Myers Chief Medical Officer sell | $7,579 3,423 shares | -7% | +55% from low-71% from high | |
| 66Notable | Robert Carey director buy | $2.0M 1,200,000 shares | +102% | +19% from low-78% from high | |
| 55Moderate | Steven A. Lisi CEO and Chairman of the Board buy | $127k 77,775 shares | +5% | +19% from low-78% from high | |
| 31Weak | Michael A. Gaul Chief Operating Officer buy | $18k 10,000 shares | +13% | +13% from low-79% from high |
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Dec 29, 2023 | Avniel Amir Director | 50,000 0.16% of outstanding | $109k | Dec 28, 2023 | none |
Transactions
The newest 50 of 258 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 29, 2026 | Yi-Chien Lin owner | POpen-market purchase Common Stock | +3,000 | $2.69 | $8,070 | 128,000 | 12 d ago |
| Sep 30, 2026 | Yi-Chien Lin owner | POpen-market purchase Common Stock | +2,000 | $2.71 | $5,420 | 130,000 | 12 d ago |
| Oct 1, 2026 | Yi-Chien Lin owner | POpen-market purchase Common Stock | +15,393 | $2.80 | $43k | 145,393 | 12 d ago |
| Jul 29, 2026 | Daniel J Moorhead Chief Financial Officer | POpen-market purchase Common Stock | +4,340 | $5.76 | $25k | 4,340 | Jul 31, 2026 |
| Jul 29, 2026 | Robert Scott Goodman Chief Executive Officer | POpen-market purchase Common Stock | +34,722 | $5.76 | $200k | 34,822 | Jul 31, 2026 |
| Jul 29, 2026 | Daniel J Moorhead Chief Financial Officer | POpen-market purchase Series A Warrantderivative | +4,340 | - | - | 4,340 | Jul 31, 2026 |
| Jul 29, 2026 | Robert Scott Goodman Chief Executive Officer | POpen-market purchase Series A Warrantsderivative | +34,722 | - | - | 34,722 | Jul 31, 2026 |
| Jul 29, 2026 | Daniel J Moorhead Chief Financial Officer | POpen-market purchase Series B Warrantderivative | +4,340 | - | - | 4,340 | Jul 31, 2026 |
| Jul 29, 2026 | Robert Scott Goodman Chief Executive Officer | POpen-market purchase Series B Warrantsderivative | +34,722 | - | - | 34,722 | Jul 31, 2026 |
| Jan 5, 2026 | Daniel J Moorhead Chief Financial Officer | AGrant or award Stock Option (right to buy)derivative | +70,000 | - | - | 70,000 | Jan 6, 2026 |
| Nov 4, 2025 | Yoori Lee director | DDisposition to issuer Stock Options (Right to buy)derivative | -2,250 | - | - | 0 | Nov 24, 2025 |
| Nov 4, 2025 | Michael A. Gaul Chief Operating Officer | DDisposition to issuer Stock Options (Right to buy)derivative | -17,500 | - | - | 0 | Nov 24, 2025 |
| Nov 4, 2025 | Yoori Lee director | AGrant or award Stock Options (Right to buy)derivative | +2,250 | - | - | 2,250 | Nov 24, 2025 |
| Nov 4, 2025 | Michael A. Gaul Chief Operating Officer | AGrant or award Stock Options (Right to buy)derivative | +17,500 | - | - | 17,500 | Nov 24, 2025 |
| Nov 4, 2025 | Yoori Lee director | DDisposition to issuer Stock Options (Right to buy)derivative | -2,000 | - | - | 0 | Nov 24, 2025 |
| Nov 4, 2025 | Michael A. Gaul Chief Operating Officer | DDisposition to issuer Stock Options (Right to buy)derivative | -8,500 | - | - | 0 | Nov 24, 2025 |
| Nov 4, 2025 | Yoori Lee director | AGrant or award Stock Options (Right to buy)derivative | +2,000 | - | - | 2,000 | Nov 24, 2025 |
| Nov 4, 2025 | Michael A. Gaul Chief Operating Officer | AGrant or award Stock Options (Right to buy)derivative | +8,500 | - | - | 8,500 | Nov 24, 2025 |
| Nov 4, 2025 | Yoori Lee director | DDisposition to issuer Stock Options (Right to buy)derivative | -1,500 | - | - | 0 | Nov 24, 2025 |
| Nov 4, 2025 | Michael A. Gaul Chief Operating Officer | DDisposition to issuer Stock Options (Right to buy)derivative | -3,500 | - | - | 0 | Nov 24, 2025 |
| Nov 4, 2025 | Michael A. Gaul Chief Operating Officer | AGrant or award Stock Options (Right to buy)derivative | +3,500 | - | - | 3,500 | Nov 24, 2025 |
| Nov 4, 2025 | Yoori Lee director | AGrant or award Stock Options (Right to buy)derivative | +1,500 | - | - | 1,500 | Nov 24, 2025 |
| Nov 4, 2025 | Yoori Lee director | DDisposition to issuer Stock Options (Right to buy)derivative | -1,250 | - | - | 0 | Nov 24, 2025 |
| Nov 4, 2025 | Michael A. Gaul Chief Operating Officer | DDisposition to issuer Stock Options (Right to buy)derivative | -1,250 | - | - | 0 | Nov 24, 2025 |
| Nov 4, 2025 | Yoori Lee director | AGrant or award Stock Options (Right to buy)derivative | +1,250 | - | - | 1,250 | Nov 24, 2025 |
| Nov 4, 2025 | Michael A. Gaul Chief Operating Officer | AGrant or award Stock Options (Right to buy)derivative | +1,250 | - | - | 1,250 | Nov 24, 2025 |
| Nov 4, 2025 | Michael A. Gaul Chief Operating Officer | DDisposition to issuer Stock Options (Right to buy)derivative | -500 | - | - | 0 | Nov 24, 2025 |
| Nov 4, 2025 | Yoori Lee director | DDisposition to issuer Stock Options (Right to buy)derivative | -1,250 | - | - | 0 | Nov 24, 2025 |
| Nov 4, 2025 | Michael A. Gaul Chief Operating Officer | AGrant or award Stock Options (Right to buy)derivative | +500 | - | - | 500 | Nov 24, 2025 |
| Nov 4, 2025 | Yoori Lee director | AGrant or award Stock Options (Right to buy)derivative | +1,250 | - | - | 1,250 | Nov 24, 2025 |
| Nov 4, 2025 | Michael A. Gaul Chief Operating Officer | DDisposition to issuer Stock Options (Right to buy)derivative | -2,000 | - | - | 0 | Nov 24, 2025 |
| Nov 4, 2025 | Yoori Lee director | DDisposition to issuer Stock Options (Right to buy)derivative | -750 | - | - | 0 | Nov 24, 2025 |
| Nov 4, 2025 | Yoori Lee director | AGrant or award Stock Options (Right to buy)derivative | +750 | - | - | 750 | Nov 24, 2025 |
| Nov 4, 2025 | Michael A. Gaul Chief Operating Officer | AGrant or award Stock Options (Right to buy)derivative | +2,000 | - | - | 2,000 | Nov 24, 2025 |
| Nov 4, 2025 | Yoori Lee director | DDisposition to issuer Stock Options (Right to buy)derivative | -1,250 | - | - | 0 | Nov 24, 2025 |
| Nov 4, 2025 | Michael A. Gaul Chief Operating Officer | DDisposition to issuer Stock Options (Right to buy)derivative | -20,000 | - | - | 0 | Nov 24, 2025 |
| Nov 4, 2025 | Yoori Lee director | AGrant or award Stock Options (Right to buy)derivative | +1,250 | - | - | 1,250 | Nov 24, 2025 |
| Nov 4, 2025 | Michael A. Gaul Chief Operating Officer | AGrant or award Stock Options (Right to buy)derivative | +20,000 | - | - | 20,000 | Nov 24, 2025 |
| Nov 4, 2025 | Yoori Lee director | DDisposition to issuer Stock Options (Right to buy)derivative | -3,750 | - | - | 0 | Nov 24, 2025 |
| Nov 4, 2025 | Yoori Lee director | AGrant or award Stock Options (Right to buy)derivative | +3,750 | - | - | 3,750 | Nov 24, 2025 |
| Nov 4, 2025 | Robert Carey director | DDisposition to issuer Stock Options (Right to buy)derivative | -4,500 | - | - | 0 | Nov 7, 2025 |
| Nov 3, 2025 | Robert Carey director | JOther Warrants to purchase Common Stockderivative | +512,821 | - | - | 512,821 | Nov 7, 2025 |
| Nov 4, 2025 | Robert Carey director | AGrant or award Stock Options (Right to buy)derivative | +4,500 | - | - | 4,500 | Nov 7, 2025 |
| Nov 3, 2025 | Robert Carey director | DDisposition to issuer Warrants to purchase Common Stockderivative | -494,332 | - | - | 0 | Nov 7, 2025 |
| Nov 3, 2025 | Robert Carey director | AGrant or award Warrants to purchase Common Stockderivative | +494,332 | - | - | 494,332 | Nov 7, 2025 |
| Nov 4, 2025 | Robert Carey director | DDisposition to issuer Stock Options (Right to buy)derivative | -2,000 | - | - | 0 | Nov 7, 2025 |
| Nov 4, 2025 | Robert Carey director | AGrant or award Stock Options (Right to buy)derivative | +2,000 | - | - | 2,000 | Nov 7, 2025 |
| Nov 4, 2025 | Robert Carey director | DDisposition to issuer Stock Options (Right to buy)derivative | -1,500 | - | - | 0 | Nov 7, 2025 |
| Nov 4, 2025 | Robert Carey director | AGrant or award Stock Options (Right to buy)derivative | +1,500 | - | - | 1,500 | Nov 7, 2025 |
| Nov 4, 2025 | Robert Carey director | DDisposition to issuer Stock Options (Right to buy)derivative | -1,250 | - | - | 0 | Nov 7, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Amir AvnielChief Business Officer
- Robert Careydirector
- Michael A. GaulChief Operating Officer
- Robert Scott GoodmanChief Executive Officer
- Yoori Leedirector
- Yi-Chien Linowner
- Steven A. LisiCEO and Chairman of the Board
- Daniel J MoorheadChief Financial Officer
- Jeff Lynn MyersChief Medical Officer
Questions about XAIR
Answered from the filings on this page, as of the latest one.
Are insiders buying XAIR?
As of Oct 2, 2026, SEC Form 4 filings show 3 open-market buys worth $282k by 3 insiders and 0 open-market sells worth $0 by 0 insiders at Beyond Air, Inc. in the last 90 days, net +$282k. Only purchases (code P) and sales (code S) count; grants, option exercises and tax withholding do not.
Who was the last insider to trade XAIR on the open market?
Yi-Chien Lin (10% owner) bought $57k of XAIR on Sep 29, 2026 and filed the Form 4 on Oct 2, 2026. InsiderTell scored 35 (weak).
How many insiders file Form 4 at Beyond Air, Inc.?
9 people have filed a Form 4 at Beyond Air, Inc., among them Amir Avniel (Chief Business Officer), Robert Carey (director), Michael A. Gaul (Chief Operating Officer). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.